Khattar Jack A., President and CEO of Supernus Pharmaceuticals ($SUPN), sold shares on the open market 17 times over the last year, totaling $18.5 million. His most recent sale occurred on October 9, 2025. These $SUPN insider sales rank 718th among 11,678 individual insiders in our database, surpassing the average sale value of $8.6 million across 6.4 transactions. Khattar made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 24138 | $50.09 | 2,210,106.0000 | 56,552,741 | 1.08% | 0.04% |
| March 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | J | Common Stock | 12500 | $0.00 | 2,234,244.0000 | 56,552,741 | 0.56% | 0.02% |
| March 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | J | Common Stock | 12500 | $0.00 | 2,199,244.0000 | 56,552,741 | 0.57% | 0.02% |
| March 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 10742 | $51.00 | 2,199,364.0000 | 56,552,741 | 0.49% | 0.02% |
| March 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 120 | $51.75 | 2,199,244.0000 | 56,552,741 | 0.01% | 0.00% |
| March 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 38640 | $0.00 | 2,250,818.0000 | 56,552,741 | 1.75% | 0.07% |
| March 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 38640 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.07% |
| March 6, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 16574 | $54.73 | 2,234,244.0000 | 56,552,741 | 0.74% | 0.03% |
| Feb. 28, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 38640 | $0.00 | 38,640.0000 | 56,552,741 | 9999.99% | 0.07% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Employee Stock Option (Right to Buy) | 341610 | $0.00 | 341,610.0000 | 56,552,741 | 9999.99% | 0.60% |
| Oct. 9, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 81250 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.14% |
| Oct. 9, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 81250 | $25.30 | 2,272,078.0000 | 56,552,741 | 3.71% | 0.14% |
| Oct. 9, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 58371 | $50.55 | 2,213,707.0000 | 56,552,741 | 2.57% | 0.10% |
| Oct. 9, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 1529 | $51.46 | 2,212,178.0000 | 56,552,741 | 0.07% | 0.00% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Khattar Jack A. | Not found | D | Stock Option (Right to Buy) | 19750 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.04% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Khattar Jack A. | Not found | U | Common Stock | 5000 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.01% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Khattar Jack A. | Not found | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.06% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Khattar Jack A. | Not found | D | Stock Option (Right to Buy) | 6124 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.01% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Khattar Jack A. | Not found | D | Stock Option (Right to Buy) | 16300 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.03% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 19320 | $0.00 | 2,198,357.0000 | 56,552,741 | 0.89% | 0.03% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 2267 | $0.00 | 81,250.0000 | 56,552,741 | 2.71% | 0.00% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 1904 | $48.06 | 2,166,833.0000 | 56,552,741 | 0.09% | 0.00% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 2267 | $25.30 | 2,168,737.0000 | 56,552,741 | 0.10% | 0.00% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Units | 19320 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.03% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 20000 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.04% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 7796 | $46.21 | 2,179,037.0000 | 56,552,741 | 0.36% | 0.01% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 20000 | $0.00 | 2,186,833.0000 | 56,552,741 | 0.92% | 0.04% |
| Oct. 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 7529 | $46.21 | 2,190,828.0000 | 56,552,741 | 0.34% | 0.01% |
| Oct. 1, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 53785 | $0.00 | 83,517.0000 | 56,552,741 | 39.17% | 0.10% |
| Oct. 1, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 40173 | $48.07 | 2,166,470.0000 | 56,552,741 | 1.82% | 0.07% |
| Oct. 1, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 53785 | $25.30 | 2,206,643.0000 | 56,552,741 | 2.50% | 0.10% |
| Sept. 30, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 11510 | $25.30 | 2,161,446.0000 | 55,958,537 | 0.54% | 0.02% |
| Sept. 30, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 11510 | $0.00 | 137,302.0000 | 55,958,537 | 7.73% | 0.02% |
| Sept. 30, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 8588 | $48.25 | 2,152,858.0000 | 55,958,537 | 0.40% | 0.02% |
| Sept. 29, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 13688 | $0.00 | 148,812.0000 | 55,958,537 | 8.42% | 0.02% |
| Sept. 29, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 10235 | $48.02 | 2,149,936.0000 | 55,958,537 | 0.47% | 0.02% |
| Sept. 29, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 13688 | $25.30 | 2,160,171.0000 | 55,958,537 | 0.64% | 0.02% |
| Sept. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 47940 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.09% |
| Sept. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 29513 | $47.23 | 2,146,483.0000 | 55,958,537 | 1.36% | 0.05% |
| Sept. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 47940 | $12.98 | 2,175,996.0000 | 55,958,537 | 2.25% | 0.09% |
| Sept. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 27060 | $0.00 | 47,940.0000 | 55,958,537 | 36.08% | 0.05% |
| Sept. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 16587 | $47.02 | 2,128,056.0000 | 55,958,537 | 0.77% | 0.03% |
| Sept. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 27060 | $12.98 | 2,144,643.0000 | 55,958,537 | 1.28% | 0.05% |
| Sept. 10, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 20000 | $0.00 | 20,000.0000 | 55,958,537 | 9999.99% | 0.04% |
| Sept. 10, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Units | 19320 | $0.00 | 19,320.0000 | 55,958,537 | 9999.99% | 0.03% |
| Sept. 8, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 8074 | $25.30 | 1,118,305.0000 | 55,958,537 | 0.73% | 0.01% |
| Sept. 8, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 6322 | $46.29 | 1,111,983.0000 | 55,958,537 | 0.57% | 0.01% |
| Sept. 8, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 8074 | $0.00 | 162,500.0000 | 55,958,537 | 4.73% | 0.01% |
| Sept. 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 73176 | $0.00 | 170,574.0000 | 55,958,537 | 30.02% | 0.13% |
| Sept. 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 55578 | $46.01 | 2,115,831.0000 | 55,958,537 | 2.56% | 0.10% |
| Sept. 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 73176 | $25.30 | 2,171,409.0000 | 55,958,537 | 3.49% | 0.13% |
| Aug. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 24150 | $45.12 | 2,098,233.0000 | 55,958,537 | 1.14% | 0.04% |
| Aug. 27, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 17195 | $0.00 | 113,779.0000 | 55,958,537 | 13.13% | 0.03% |
| Aug. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 38779 | $0.00 | 75,000.0000 | 55,958,537 | 34.08% | 0.07% |
| Aug. 27, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 17195 | $12.98 | 2,094,254.0000 | 55,958,537 | 0.83% | 0.03% |
| Aug. 27, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 10650 | $45.05 | 2,083,604.0000 | 55,958,537 | 0.51% | 0.02% |
| Aug. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 38779 | $12.98 | 2,122,383.0000 | 55,958,537 | 1.86% | 0.07% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 1611 | $0.00 | 130,974.0000 | 55,958,537 | 1.22% | 0.00% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 1000 | $45.00 | 2,077,059.0000 | 55,958,537 | 0.05% | 0.00% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 1611 | $12.98 | 2,078,059.0000 | 55,958,537 | 0.08% | 0.00% |
| Aug. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 1500 | $45.00 | 2,076,448.0000 | 55,958,537 | 0.07% | 0.00% |
| Aug. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 2415 | $0.00 | 132,585.0000 | 55,958,537 | 1.79% | 0.00% |
| Aug. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 2415 | $12.98 | 2,077,948.0000 | 55,958,537 | 0.12% | 0.00% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 81250 | $0.00 | 243,750.0000 | 55,958,537 | 25.00% | 0.15% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 60000 | $0.00 | 135,000.0000 | 55,958,537 | 30.77% | 0.11% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 60000 | $0.00 | 195,000.0000 | 55,958,537 | 23.53% | 0.11% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 63500 | $43.12 | 2,075,533.0000 | 55,958,537 | 2.97% | 0.11% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 81250 | $25.30 | 2,139,033.0000 | 55,958,537 | 3.95% | 0.15% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 38000 | $42.00 | 2,057,783.0000 | 55,958,537 | 1.81% | 0.07% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 60000 | $12.98 | 2,095,783.0000 | 55,958,537 | 2.95% | 0.11% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 38500 | $40.24 | 2,035,783.0000 | 55,958,537 | 1.86% | 0.07% |
| Aug. 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 60000 | $12.98 | 2,074,283.0000 | 55,958,537 | 2.98% | 0.11% |
| June 18, 2025 | COGNITION THERAPEUTICS INC | $CGTX | Khattar Jack A. | Director | A | Common Stock | 34000 | $0.00 | 48,500.0000 | 61,828,149 | 234.48% | 0.05% |
| June 3, 2025 | scPharmaceuticals Inc. | $SCPH | Khattar Jack A. | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 44,519,669 | 9999.99% | 0.07% |
| April 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | J | Common Stock | 16850 | $0.00 | 2,014,283.0000 | 55,958,537 | 0.83% | 0.03% |
| April 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | J | Common Stock | 16850 | $0.00 | 2,014,283.0000 | 55,958,537 | 0.84% | 0.03% |
| March 10, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 35000 | $0.00 | 2,031,088.0000 | 55,958,537 | 1.75% | 0.06% |
| March 10, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 16805 | $32.06 | 2,014,283.0000 | 55,958,537 | 0.83% | 0.03% |
| March 10, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 35000 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.06% |
| March 7, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 18581 | $39.11 | 1,996,088.0000 | 55,958,537 | 0.92% | 0.03% |
| March 7, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 38640 | $0.00 | 2,014,669.0000 | 55,958,537 | 1.96% | 0.07% |
| March 7, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Units | 38640 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.07% |
| Feb. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 35000 | $0.00 | 35,000.0000 | 55,958,537 | 9999.99% | 0.06% |
| Feb. 20, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Employee Stock Option (Right to Buy) | 331660 | $0.00 | 331,660.0000 | 55,958,537 | 9999.99% | 0.59% |
| Feb. 17, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Units | 38640 | $0.00 | 38,640.0000 | 55,958,537 | 9999.99% | 0.07% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 14000 | $0.00 | 0.0000 | 56,016,350 | 100.00% | 0.02% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 38640 | $0.00 | 0.0000 | 56,016,350 | 100.00% | 0.07% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 6666 | $35.59 | 1,976,029.0000 | 56,016,350 | 0.34% | 0.01% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 38640 | $0.00 | 1,987,262.0000 | 56,016,350 | 1.98% | 0.07% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 18567 | $35.59 | 1,968,695.0000 | 56,016,350 | 0.93% | 0.03% |
| Dec. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 14000 | $0.00 | 1,982,695.0000 | 56,016,350 | 0.71% | 0.02% |
| Dec. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 38640 | $0.00 | 38,640.0000 | 56,016,350 | 9999.99% | 0.07% |
| Dec. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 14000 | $0.00 | 14,000.0000 | 56,016,350 | 9999.99% | 0.02% |
| Nov. 8, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 125000 | $36.29 | 1,948,622.0000 | 56,016,350 | 6.03% | 0.22% |
| Nov. 8, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 125000 | $0.00 | 0.0000 | 56,016,350 | 100.00% | 0.22% |
| Nov. 8, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 125000 | $9.13 | 2,073,622.0000 | 56,016,350 | 6.41% | 0.22% |
| Nov. 7, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 125000 | $36.68 | 1,948,622.0000 | 56,016,350 | 6.03% | 0.22% |
| Nov. 7, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 125000 | $9.13 | 2,073,622.0000 | 56,016,350 | 6.41% | 0.22% |
| Nov. 7, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 56,016,350 | 50.00% | 0.22% |
| Sept. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 10045 | $34.90 | 1,948,622.0000 | 55,506,828 | 0.51% | 0.02% |
| Sept. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 21000 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.04% |
| Sept. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 21000 | $0.00 | 1,958,667.0000 | 55,506,828 | 1.08% | 0.04% |
| Aug. 27, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 21000 | $0.00 | 21,000.0000 | 55,506,828 | 9999.99% | 0.04% |
| June 11, 2024 | scPharmaceuticals Inc. | $SCPH | Khattar Jack A. | Not found | A | Stock Option (Right to Buy) | 19750 | $0.00 | 19,750.0000 | 38,513,747 | 9999.99% | 0.05% |
| June 7, 2024 | COGNITION THERAPEUTICS INC | $CGTX | Khattar Jack A. | Director | A | Stock Option (right to buy) | 8500 | $0.00 | 8,500.0000 | 33,735,269 | 9999.99% | 0.03% |
| June 7, 2024 | COGNITION THERAPEUTICS INC | $CGTX | Khattar Jack A. | Director | A | Common Stock | 8500 | $0.00 | 14,500.0000 | 33,735,269 | 141.67% | 0.03% |
| Feb. 28, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 35000 | $0.00 | 1,954,455.0000 | 55,506,828 | 1.82% | 0.06% |
| Feb. 28, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 16788 | $27.94 | 1,937,667.0000 | 55,506,828 | 0.86% | 0.03% |
| Feb. 28, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 35000 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.06% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Employee Stock Option (Right to Buy) | 322000 | $0.00 | 322,000.0000 | 55,506,828 | 9999.99% | 0.58% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 35000 | $0.00 | 35,000.0000 | 55,506,828 | 9999.99% | 0.06% |
| Feb. 12, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | J | Common Stock | 16500 | $0.00 | 1,919,455.0000 | 55,506,828 | 0.85% | 0.03% |
| Feb. 12, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | J | Common Stock | 16500 | $0.00 | 1,919,455.0000 | 55,506,828 | 0.87% | 0.03% |
| Dec. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 25000 | $0.00 | 1,931,413.0000 | 61,679,800 | 1.31% | 0.04% |
| Dec. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 25000 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.04% |
| Dec. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 11958 | $27.66 | 1,919,455.0000 | 61,679,800 | 0.62% | 0.02% |
| Dec. 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 25000 | $0.00 | 25,000.0000 | 61,679,800 | 9999.99% | 0.04% |
| Sept. 7, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 16804 | $32.10 | 1,906,413.0000 | 61,679,800 | 0.87% | 0.03% |
| Sept. 7, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 35000 | $0.00 | 1,923,217.0000 | 61,679,800 | 1.85% | 0.06% |
| Sept. 7, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 35000 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.06% |
| Aug. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 35000 | $0.00 | 35,000.0000 | 61,679,800 | 9999.99% | 0.06% |
| May 11, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 31250 | $0.00 | 1,903,222.0000 | 61,679,800 | 1.67% | 0.05% |
| May 11, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | F | Common Stock | 15005 | $36.47 | 1,888,217.0000 | 61,679,800 | 0.79% | 0.02% |
| May 11, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 31250 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.05% |
| May 4, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 31250 | $0.00 | 31,250.0000 | 61,679,800 | 9999.99% | 0.05% |
| March 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 20000 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.03% |
| March 14, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 20000 | $0.00 | 1,871,972.0000 | 61,679,800 | 1.08% | 0.03% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Employee Stock Option (Right to Buy) | 280000 | $0.00 | 280,000.0000 | 61,679,800 | 9999.99% | 0.45% |
| Feb. 16, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 20000 | $0.00 | 20,000.0000 | 61,679,800 | 9999.99% | 0.03% |
| Feb. 15, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | J | Common Stock | 8750 | $0.00 | 1,851,972.0000 | 61,679,800 | 0.47% | 0.01% |
| Feb. 15, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | J | Common Stock | 8750 | $0.00 | 1,851,972.0000 | 61,679,800 | 0.47% | 0.01% |
| Feb. 3, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 330 | $0.00 | 25,037.0000 | 61,679,800 | 1.30% | 0.00% |
| Feb. 2, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 13532 | $42.06 | 1,851,842.0000 | 61,679,800 | 0.73% | 0.02% |
| Feb. 3, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 330 | $9.56 | 1,852,172.0000 | 61,679,800 | 0.02% | 0.00% |
| Feb. 3, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 200 | $42.02 | 1,851,972.0000 | 61,679,800 | 0.01% | 0.00% |
| Feb. 2, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 22515 | $0.00 | 25,367.0000 | 61,679,800 | 47.02% | 0.04% |
| Feb. 2, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 22515 | $9.56 | 1,865,374.0000 | 61,679,800 | 1.22% | 0.04% |
| Feb. 1, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 498 | $0.00 | 47,882.0000 | 61,679,800 | 1.03% | 0.00% |
| Feb. 1, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 498 | $9.56 | 1,843,159.0000 | 61,679,800 | 0.03% | 0.00% |
| Feb. 1, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 300 | $42.01 | 1,842,859.0000 | 61,679,800 | 0.02% | 0.00% |
| Jan. 31, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 1620 | $0.00 | 48,380.0000 | 61,679,800 | 3.24% | 0.00% |
| Jan. 31, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 1620 | $9.56 | 1,843,637.0000 | 61,679,800 | 0.09% | 0.00% |
| Jan. 31, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 976 | $42.01 | 1,842,661.0000 | 61,679,800 | 0.05% | 0.00% |
| Jan. 18, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 8080 | $9.56 | 1,846,953.0000 | 61,679,800 | 0.44% | 0.01% |
| Jan. 18, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 4936 | $40.40 | 1,842,017.0000 | 61,679,800 | 0.27% | 0.01% |
| Jan. 18, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 8080 | $0.00 | 50,000.0000 | 61,679,800 | 13.91% | 0.01% |
| Jan. 17, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Employee Stock Option (Right to Buy) | 41920 | $0.00 | 58,080.0000 | 61,679,800 | 41.92% | 0.07% |
| Jan. 17, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | S | Common Stock | 25446 | $40.03 | 1,838,873.0000 | 61,679,800 | 1.36% | 0.04% |
| Jan. 17, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 41920 | $9.56 | 1,864,319.0000 | 61,679,800 | 2.30% | 0.07% |
| March 14, 2022 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Common Stock | 40000 | $0.00 | 1,618,916.0000 | 0 | 2.53% | 0.00% |
| March 14, 2022 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Common Stock | 20000 | $0.00 | 1,638,916.0000 | 0 | 1.24% | 0.00% |
| March 14, 2022 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | M | Performance Share Unit | 40000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 30, 2021 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Khattar Jack A. | President, CEO | A | Performance Share Unit | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |